Aurobindo Pharma informs about disclosure

27 Sep 2023 Evaluate
Aurobindo Pharma has informed that Auro Vaccines, a wholly owned subsidiary of the Company, has entered into a Licence Agreement with Hilleman Laboratories Singapore, to develop, manufacture and commercialise a pentavalent vaccine candidate used in children vaccination.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1197.20 -15.10 (-1.25%)
01-Feb-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.70
Dr. Reddys Lab 1226.45
Cipla 1322.40
Zydus Lifesciences 884.50
Lupin 2115.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×